Metacognition in Schizophrenia Spectrum Disorders: From Research to Clinical Practice

A special issue of Behavioral Sciences (ISSN 2076-328X).

Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 3222

Special Issue Editor


E-Mail Website
Guest Editor
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, 28009 Madrid, Spain
Interests: schizophrenia spectrum disorders; suicidal behavior; insight; metacognition

Special Issue Information

Dear Colleagues,

I am pleased to invite you to submit your manuscript(s) to Behavioral Sciences for the Special Issue “Metacognition in Schizophrenia Spectrum Disorders: From Research to Clinical Practice ”.

Metacognition may be defined as “knowledge and cognition about cognitive phenomena” (Flavell, 1979) or “the ability to think of one’s and others’ thinking” (Wells and Purdon, 1999). Interestingly, patients with schizophrenia spectrum disorders (SSD), undoubtedly the most serious mental illness, have been consistently found to have poorer metacognitive performance than the general population (Beck et al., 2004). Most importantly, these metacognitive deficits were linked with more severe psychotic symptoms (Lysaker et al., 2018), including impaired insight (David, 2019), and poorer clinical and social outcomes (Lysaker et al., 2018). Interestingly, metacognitive interventions were shown to reduce symptom severity (Philipp et al., 2019) and improve insight (Lopez-Morinigo et al., 2020), although the impact of these therapies on long-term clinical and social outcomes remains to be established.

Within this context, we encourage researchers in the field to submit your findings for publication in this Special Issue, of which patients (and their families and carers) should become the main recipients.

I look forward to receiving your manuscripts. 

References

Beck, A.T., Baruch, E., Balter, J.M., Steer, R.A., Warman, D.M., 2004. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr. Res. 68, 319–329. https://doi.org/10.1016/S0920-9964(03)00189-0

David, A.S., 2019. Insight and psychosis: the next 30 years. Br J Psychiatry 1–3. https://doi.org/10.1192/bjp.2019.217

Flavell, J.H., 1979. Metacognition and cognitive monitoring: A new area of cognitive-developmental inquiry. American Psychologist 34, 906–911. https://doi.org/10.1037/0003-066X.34.10.906

Lopez-Morinigo, J.-D., Ajnakina, O., Martínez, A.S.-E., Escobedo-Aedo, P.-J., Ruiz-Ruano, V.G., Sánchez-Alonso, S., Mata-Iturralde, L., Muñoz-Lorenzo, L., Ochoa, S., Baca-García, E., David, A.S., 2020. Can metacognitive interventions improve insight in schizophrenia spectrum disorders? A systematic review and meta-analysis. Psychol Med 50, 2289–2301. https://doi.org/10.1017/S0033291720003384

Lysaker, P.H., Pattison, M.L., Leonhardt, B.L., Phelps, S., Vohs, J.L., 2018. Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments. World Psychiatry 17, 12–23. https://doi.org/10.1002/wps.20508

Philipp, R., Kriston, L., Lanio, J., Kühne, F., Härter, M., Moritz, S., Meister, R., 2019. Effectiveness of metacognitive interventions for mental disorders in adults-A systematic review and meta-analysis (METACOG). Clin Psychol Psychother 26, 227–240. https://doi.org/10.1002/cpp.2345

Wells, A., Purdon, C., 1999. Metacognition and cognitive-behaviour therapy: A special issue. Clinical Psychology & Psychotherapy.

Kind regards,
Dr. Javier-David Lopez-Morinigo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Behavioral Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • schizophrenia spectrum disorders
  • metacognition
  • treatment
  • outcomes

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 340 KiB  
Article
Investigating the Role of Insight, Decision-Making and Mentalizing in Functional Outcome in Schizophrenia: A Cross-Sectional Study
by Paula Jhoana Escobedo-Aedo, Ana Forjan-González, Adela Sánchez-Escribano Martínez, Verónica González Ruiz-Ruano, Sergio Sánchez-Alonso, Laura Mata-Iturralde, Laura Muñoz-Lorenzo, Enrique Baca-García, Anthony S. David and Javier-David Lopez-Morinigo
Behav. Sci. 2022, 12(2), 28; https://doi.org/10.3390/bs12020028 - 27 Jan 2022
Cited by 3 | Viewed by 2685
Abstract
Background: Recovery has become a priority in schizophrenia spectrum disorders (SSDs). This study aimed to investigate predictors of objective—general functioning and disability—and subjective—quality of life (QoL)—measures of functional outcomes in SSD. Methods: Sample: n = 77 SSD outpatients (age 18–64, IQ > 70) [...] Read more.
Background: Recovery has become a priority in schizophrenia spectrum disorders (SSDs). This study aimed to investigate predictors of objective—general functioning and disability—and subjective—quality of life (QoL)—measures of functional outcomes in SSD. Methods: Sample: n = 77 SSD outpatients (age 18–64, IQ > 70) participating in a randomised controlled trial. Baseline data were used to build three multivariable linear regression models on: (i) general functioning—General Assessment of Functioning (GAF); (ii) disability—the World Health Organization Disability Assessment Schedule (WHODAS-2.0); and (iii) QoL—Satisfaction Life Domains Scale (SLDS). Results: Young age and being employed (R2 change = 0.211; p = 0.001), late adolescence premorbid adjustment (R2 change = 0.049; p = 0.0050), negative symptoms and disorganization (R2 change = 0.087; p = 0.025) and Theory of Mind (R2 change = 0.066, p = 0.053) predicted general functioning. Previous suicidal behaviour (R2 change = 0.068; p = 0.023) and negative and depressive symptoms (R2 change = 0.167; p = 0.001) were linked with disability. Previous suicidal behaviour (R2 change = 0.070, p = 0.026), depressive symptoms (R2 change = 0.157; p < 0.001) and illness recognition (R2 change = 0.046, p = 0.044) predicted QoL. Conclusions: Negative, disorganization and depressive symptoms, older age, unemployment, poor premorbid adjustment, previous suicide attempts and illness awareness appear to underlie a poor global functional outcome in SSD. Achieving recovery in SSD appears to require both symptomatic remission (e.g., through antipsychotics) and measures to improve mastery and relieve low mood. Full article
Back to TopTop